Total Payments
$15,910
2024 Payments
$3,210
Companies
40
Transactions
709
Medicare Patients
12,535
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$15,060 (94.7%)
Other$500.00 (3.1%)
Education$349.92 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,060 | 702 | 94.7% |
| Honoraria | $500.00 | 1 | 3.1% |
| Education | $349.92 | 6 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,893 | 95 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,313 | 79 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,281 | 51 | $0 (2024) |
| Janssen Biotech, Inc. | $1,278 | 51 | $0 (2024) |
| GENZYME CORPORATION | $1,084 | 41 | $0 (2024) |
| PFIZER INC. | $810.97 | 45 | $0 (2024) |
| LEO Pharma Inc. | $720.40 | 35 | $0 (2024) |
| Dermavant Sciences, Inc. | $669.92 | 38 | $0 (2024) |
| Encore Dermatology Inc. | $625.11 | 3 | $0 (2018) |
| Incyte Corporation | $604.14 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,210 | 149 | GENZYME CORPORATION ($428.80) |
| 2023 | $3,355 | 152 | Janssen Biotech, Inc. ($441.09) |
| 2022 | $2,212 | 117 | ABBVIE INC. ($431.42) |
| 2021 | $1,193 | 70 | Janssen Biotech, Inc. ($160.43) |
| 2020 | $496.04 | 22 | Janssen Biotech, Inc. ($152.56) |
| 2019 | $1,358 | 62 | AbbVie, Inc. ($280.47) |
| 2018 | $2,301 | 75 | Encore Dermatology Inc. ($599.99) |
| 2017 | $1,784 | 62 | Allergan Inc. ($298.58) |
All Payment Transactions
709 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Inflammation & Immunology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.49 | General |
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.38 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation & Immunology | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.74 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $38.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.85 | General |
| Category: Immunology | ||||||
| 11/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: DERMATOLOGY | ||||||
| 11/03/2024 | Medimetriks Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.34 | General |
| 11/01/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Inflammation & Immunology | ||||||
| 10/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 3,324 | 4,783 | $1.2M | $296,456 |
| 2022 | 17 | 3,330 | 4,842 | $1.2M | $297,979 |
| 2021 | 17 | 3,194 | 4,410 | $1.1M | $291,510 |
| 2020 | 14 | 2,687 | 3,861 | $643,713 | $208,601 |
Total Patients
12,535
Total Services
17,896
Medicare Billing
$1.1M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 787 | 1,024 | $430,080 | $102,613 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 669 | 778 | $231,066 | $54,704 | 23.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 398 | 463 | $156,494 | $39,005 | 24.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 447 | 575 | $128,225 | $26,502 | 20.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 226 | 247 | $93,366 | $24,256 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $54,700 | $11,978 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $42,804 | $9,974 | 23.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 306 | 1,142 | $26,266 | $7,132 | 27.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 85 | 120 | $20,160 | $5,787 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 80 | $14,880 | $3,906 | 26.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 22 | $13,068 | $3,597 | 27.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 19 | 19 | $9,348 | $2,332 | 24.9% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 25 | 28 | $9,324 | $2,024 | 21.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 15 | 15 | $6,255 | $1,784 | 28.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 24 | $4,560 | $840.50 | 18.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 30 | $720.00 | $22.31 | 3.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 867 | 1,104 | $459,264 | $109,846 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 514 | 611 | $180,245 | $44,458 | 24.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 436 | 492 | $166,296 | $41,987 | 25.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 460 | 585 | $129,285 | $27,463 | 21.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 172 | 196 | $73,304 | $19,750 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 202 | 202 | $73,730 | $14,836 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $46,155 | $11,612 | 25.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 313 | 1,232 | $28,336 | $7,850 | 27.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 87 | 105 | $17,745 | $5,155 | 29.0% |
About Dr. Amy Cole, MD
Dr. Amy Cole, MD is a Dermatology healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275623084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Cole, MD has received a total of $15,910 in payments from pharmaceutical and medical device companies, with $3,210 received in 2024. These payments were reported across 709 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($15,060).
As a Medicare-enrolled provider, Cole has provided services to 12,535 Medicare beneficiaries, totaling 17,896 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Silver Spring, MD
- Active Since 10/13/2006
- Last Updated 02/18/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1275623084
Products in Payments
- DUPIXENT (Biological) $1,070
- TREMFYA (Drug) $890.91
- COSENTYX (Biological) $755.34
- SKYRIZI (Biological) $708.24
- EUCRISA (Drug) $690.59
- VTAMA (Drug) $669.92
- Impoyz (Drug) $599.99
- TALTZ (Drug) $555.52
- COSENTYX (Drug) $525.33
- OPZELURA (Drug) $514.15
- Otezla (Drug) $489.74
- Sotyktu (Drug) $487.03
- Humira (Biological) $467.45
- ADBRY (Biological) $460.58
- RINVOQ (Biological) $406.88
- SPEVIGO (Drug) $274.66
- ORACEA (Drug) $260.69
- ENSTILAR (Drug) $259.82
- SOOLANTRA (Drug) $248.86
- Cimzia (Drug) $245.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Silver Spring
Dr. Benjamin Lockshin, Md, MD
Dermatology — Payments: $4.1M
Dermatology $4.1M
Dr. Eleanor Ford, Md, MD
Dermatology — Payments: $4,364
Dermatology $4,364
Dr. Norman Lockshin, Md, MD
Dermatology — Payments: $3,753
Dermatology $3,753
Kavita Goyal, M.d, M.D
Dermatology — Payments: $1,414
Dermatology $1,414
Michelle Levender, Md, MD
Dermatology — Payments: $1,410
Dermatology $1,410
Edward Cowen, M.d, M.D
Dermatology — Payments: $762.26
Dermatology $762.26